Convatec Group (CHIX:CTECL) FFO


CHIX:CTECL Convatec Group PLC CHIX:CTECL
77 GF Score
Price £2.23
GF Value £2.55
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Convatec Group FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:CTECL
77GF Score
Convatec Group PLC CHIX:CTECL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Convatec Group (CHIX:CTECL) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of £2.23 is trading 12.5% below its estimated GF Value™ of £2.55. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for CHIX:CTECL:

  • FFO:
  • GF Value™: £2.55 vs. price of £2.23 (12.5% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the CHIX:CTECL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for CHIX:CTECL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.23
Price
£2.55
GF Value